Your browser doesn't support javascript.
DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging.
Sepe, Sara; Rossiello, Francesca; Cancila, Valeria; Iannelli, Fabio; Matti, Valentina; Cicio, Giada; Cabrini, Matteo; Marinelli, Eugenia; Alabi, Busola R; di Lillo, Alessia; Di Napoli, Arianna; Shay, Jerry W; Tripodo, Claudio; d'Adda di Fagagna, Fabrizio.
  • Sepe S; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Rossiello F; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.
  • Iannelli F; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Matti V; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Cicio G; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Cabrini M; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.
  • Marinelli E; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Alabi BR; Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche (IGM-CNR), Pavia, Italy.
  • di Lillo A; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • Di Napoli A; Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche (IGM-CNR), Pavia, Italy.
  • Shay JW; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Tripodo C; IFOM Foundation-FIRC Institute of Molecular Oncology Foundation, Milan, Italy.
  • d'Adda di Fagagna F; Department of Clinical and Molecular Medicine, Pathology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
EMBO Rep ; 23(2): e53658, 2022 02 03.
Article in English | MEDLINE | ID: covidwho-1547826
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), known to be more common in the elderly, who also show more severe symptoms and are at higher risk of hospitalization and death. Here, we show that the expression of the angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 cell receptor, increases during aging in mouse and human lungs. ACE2 expression increases upon telomere shortening or dysfunction in both cultured mammalian cells and in vivo in mice. This increase is controlled at the transcriptional level, and Ace2 promoter activity is DNA damage response (DDR)-dependent. Both pharmacological global DDR inhibition of ATM kinase activity and selective telomeric DDR inhibition by the use of antisense oligonucleotides prevent Ace2 upregulation following telomere damage in cultured cells and in mice. We propose that during aging telomere dysfunction due to telomeric shortening or damage triggers DDR activation and this causes the upregulation of ACE2, the SARS-CoV-2 cell receptor, thus contributing to make the elderly more susceptible to the infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: DNA Damage / Aging / Telomere / Angiotensin-Converting Enzyme 2 / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Aged / Animals / Humans Language: English Journal: EMBO Rep Journal subject: Molecular Biology Year: 2022 Document Type: Article Affiliation country: Embr.202153658

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: DNA Damage / Aging / Telomere / Angiotensin-Converting Enzyme 2 / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Aged / Animals / Humans Language: English Journal: EMBO Rep Journal subject: Molecular Biology Year: 2022 Document Type: Article Affiliation country: Embr.202153658